Drawing for NUTROVY

USPTO serial 99734638

NUTROVY

Reviewed by CopyMark Law Group

Status 802
Filing date
Status date
Registration date
—
Examiner
HINES, REGINA C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUTROVY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Naveen Thakur

1600 Perrineville RdSte 2-400Monroe Township, NJ 08831

Goods and services

ClassDescriptionStatusFirst use
005Health food supplements; Dietary food supplements; Natural herbal supplements; Vitamin supplements; Mineral supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 13, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 28, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 28, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 22, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2026DOCKASSIGNED TO EXAMINER—
Mar 31, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 31, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 31, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance